Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: EXAMINER ASSIGNMENT POLICY

EXAMINER ASSIGNMENT POLICY

posted on Mar 04, 2010 02:16PM

It is the policy of the Office that the * CRU *>SPE< will assign the reexamination request to an examiner different from the examiner(s) who examined the patent application. Thus, under normal circumstances, the reexamination request will not be assigned to a primary examiner or assistant examiner who was involved in any part of the examination of the patent for which reexamination is requested (e.g., by preparing/signing an action), or was so involved in the examination of the parent of the patent. This would preclude assignment of the request to an examiner who was a conferee in an appeal conference or panel review conference in an earlier concluded examination of the patent (e.g., the application for patent, a reissue, or a prior concluded reexamination proceeding). The conferee is considered to have participated in preparing the Office action which is preceded by the conference

http://www.uspto.gov/web/offices/pac/mpep/documents/2200_2236.htm

.

.

.

Be well

Share
New Message
Please login to post a reply